Yaron Finkelstein - Toxicology

Author Information

Yaron Finkelstein is a prominent researcher in the fields of Pediatric Emergency Medicine and Clinical Pharmacology & Toxicology. He is affiliated with the University of Toronto School of Medicine and the Hospital for Sick Children, located at 555 University Ave., Toronto, ON M5G1X8, Canada. His work primarily focuses on pediatric care, with a keen interest in improving emergency department protocols and management strategies for various medical conditions affecting children.

Research Contributions

Yaron Finkelstein has significantly contributed to pediatric health care research, particularly in the management of emergency situations. His recent studies include the effectiveness of mental health care models in pediatric emergency departments, safety assessments of tranexamic acid in pediatric trauma, and outcomes of children with SARS-CoV-2 infections. Moreover, his work addresses critical issues such as opioid intoxication in children and the impact of cannabis legalization on pediatric exposures. These contributions highlight his commitment to advancing pediatric emergency care and ensuring safer therapeutic approaches for young patients.

Aliases

Yaron Finkelstein is also known by the aliases Y Finkelstein, Y. Finkelstein, and Yaron Finkelstein.

Publication and Citation Metrics

Metric	Value
Citation Count	5762
H-index	38
Paper Count	204

Publications:

An Innovative Model of Pediatric Emergency Department Mental Health Care: Protocol for a Multicentre Type 1 Effectiveness-Implementation Cluster Randomized Trial

DOI: 10.1016/j.jaac.2022.04.001

Year: 2022

Effectiveness and safety of tranexamic acid in pediatric trauma: A systematic review and meta-analysis.

DOI: 10.1016/j.ajem.2022.01.069

Year: 2022

Corticosteroids and Other Treatments Administered to Children Tested for SARS-CoV-2 Infection in Emergency Departments

DOI: 10.1016/j.acap.2022.04.006

Year: 2022

Outcomes of SARS-CoV-2–Positive Youths Tested in Emergency Departments

DOI: 10.1001/jamanetworkopen.2021.42322

Year: 2022

Platelet-Activating Factor Acetylhydrolase is a Biomarker of Severe Anaphylaxis in Children.

DOI: 10.1111/all.15308

Year: 2022

Predictors of severe outcome following opioid intoxication in children.

DOI: 10.1080/15563650.2022.2038188

Year: 2022

Unintentional Pediatric Cannabis Exposures After Legalization of Recreational Cannabis in Canada

DOI: 10.1001/jamanetworkopen.2021.42521

Year: 2022

Predicting Adverse Outcomes for Shiga Toxin-Producing E. coli Infections in Emergency Departments.

DOI: 10.1016/j.jpeds.2020.12.077

Year: 2021

Probiotic stool secretory immunoglobulin A modulation in children with gastroenteritis: a randomized clinical trial

DOI: 10.1093/ajcn/nqaa369

Year: 2021

Improving the regulation of medical cannabis in Canada to better serve pediatric patients

DOI: 10.1503/cmaj.202169

Year: 2021

What are the Implications of Nucleobase Mutations in Risk Assessment?

What Are the Common Methods of Data Manipulation?

Are There Challenges to Preregistration in Toxicology?

How Are Conflicts Managed Once Identified?

What is the OECD QSAR Toolbox?

Why are Blood Counts Important in Toxicology?

How Does a Quadrupole Mass Analyzer Work?

What Role Does Toxicology Play in Oil Spill Response?

Does Boiling Water Remove All Contaminants?

Does Coxsackievirus Enhance Susceptibility to Toxins?

Partnered Content Networks

Relevant Topics